The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis
Abstract
BACKGROUND: Survival benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion was demonstrated by a prospective randomized trial for colorectal peritoneal carcinomatosis. Because of a recent substantial improvement in chemotherapy, the authors analyzed treatment options of colorectal carcinomatosis in the current era. METHODS: Consecutive patients with colorectal carcinomatosis treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion from 2001 to 2007 were included. The control group patients with carcinomatosis received contemporary chemotherapy alone. Overall survival was the primary endpoint. RESULTS: All patients underwent systemic chemotherapy. The cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion group (n = 67) was similar to the control group (n = 38) in sex, tumor grade, site of tumor origin, T status, and N status. The control group was, however, older (59 vs 51 years; P<.001). Median survival measured from the diagnosis of peritoneal disease was longer with cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion (34.7 months vs 16.8 months; P<.001). Presence of liver metastasis was a significant negative predictor of survival (hazard ratio, 2.13). CONCLUSIONS: The authors concluded that 1) contemporary chemotherapy is associated with prolonged survival among patients with carcinomatosis as compared with historical controls, and 2) addition of cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion to modern chemotherapy regimens may significantly prolong survival. Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion and systemic chemotherapy are not competitive therapies, and they both have a role in a multidisciplinary approach to patients with carcinomatosis. Cancer 2010. © 2010 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C., & Alberts, S. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.046 · Cited by 2,249
Verwaal, V. J., van Ruth, S., de Bree, E., van Slooten, G. W., van Tinteren, H., Boot, H., & Zoetmulder, F. A. N. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.187 · Cited by 2,049
Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G. J., Schlag, P. M., Rougier, P., Bechstein, W. O., Primrose, J. N., Walpole, E. T., Finch-Jones, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60455-9 · Cited by 1,937
Nordlinger, B., Guiguet, M., Vaillant, J.-C., Balladur, P., Boudjema, K., Bachellier, P., Jaeck, D., & Association Française de Chirurgie (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1254::aid-cncr5>3.0.co;2-i · Cited by 1,722
Sadeghi, B., Arvieux, C., Glehen, O., Beaujard, A. C., Rivoire, M., Baulieux, J., Fontaumard, E., Brachet, A., Caillot, J. L., Faure, J. L., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o · Cited by 1,200
Glehen, O., Kwiatkowski, F., Sugarbaker, P. H., Elias, D., Levine, E. A., De Simone, M., Barone, R., Yonemura, Y., Cavaliere, F., Quenet, F., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.012 · Cited by 1,184
Verwaal, V. J., Bruin, S., Boot, H., van Slooten, G., & van Tinteren, H. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9966-2 · Cited by 1,033
Elias, D., Lefevre, J. H., Chevalier, J., Brouquet, A., Marchal, F., Classe, J.-M., Ferron, G., Guilloit, J.-M., Meeus, P., Goéré, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7160 · Cited by 876
Peritoneal carcinomatosis from colorectal cancer
Jayne, D. G., Fook, S., Loi, C., & Seow-Choen, F. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02274.x · Cited by 831
Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors
Chu, D. Z. J., Lang, N. P., Thompson, C., Osteen, P. K., & Westbrook, K. C. (1989) · Cancer · doi:10.1002/1097-0142(19890115)63:2<364::aid-cncr2820630228>3.0.co;2-v · Cited by 598
Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies
Koppe, M. J., Boerman, O. C., Oyen, W. J. G., & Bleichrodt, R. P. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000197702.46394.16 · Cited by 507
Cao, C., Yan, T. D., Black, D., & Morris, D. L. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0487-4 · Cited by 250
Elias, D. M., Delpéro, J., Sidéris, L., Benhamou, E., Pocard, M. D., Baton, O., Giovannini, M. F., & Lasser, P. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.09.008 · Cited by 211
Outcomes after Resection of Synchronous or Metachronous Hepatic and Pulmonary Colorectal Metastases
Miller, G., Biernacki, P., Kemeny, N. E., Gonen, M., Downey, R., Jarnagin, W. R., D’Angelica, M., Fong, Y., Blumgart, L. H., & DeMatteo, R. P. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.04.039 · Cited by 203
Peritoneal carcinomatosis of colorectal origin
Elias, D., Raynard, B., Farkhondeh, F., Goéré, D., Rouquie, D., Ciuchendea, R., Pocard, M., & Ducreux, M. (2006) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(06)73512-6 · Cited by 165
McQuellon, R. P., Loggie, B. W., Lehman, A. B., Russell, G. B., Fleming, R. A., Shen, P., & Levine, E. A. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.067 · Cited by 156
Dy, G. K., Hobday, T. J., Nelson, G. D., Windschitl, H. E., O’Connell, M. J., Alberts, S. R., Goldberg, R. M., Nikcevich, D. A., & Sargent, D. J. (2009) · Clinical Colorectal Cancer · doi:10.3816/ccc.2009.n.014 · Cited by 79
Shen, P., Thai, K., Stewart, J. H., Howerton, R. M., Loggie, B. W., Russell, G. B., & Levine, E. A. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0127-4 · Cited by 71
Cited by
Franko, J., Shi, Q., Meyers, J. P., Maughan, T. S., Adams, R. A., Seymour, M. T., Saltz, L., Punt, C. J. A., Koopman, M., Tournigand, C., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30500-9 · Cited by 684
Self-citationFranko, J., Shi, Q., Goldman, C. D., Pockaj, B. A., Nelson, G. D., Goldberg, R. M., Pitot, H. C., Grothey, A., Alberts, S. R., & Sargent, D. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.1039 · Cited by 587
Self-citationIncidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
Segelman, J., Granath, F., Holm, T., Machado, M., Mahteme, H., & Martling, A. (2012) · British Journal of Surgery · doi:10.1002/bjs.8679 · Cited by 507
Vogel, J. D., Felder, S. I., Bhama, A. R., Hawkins, A. T., Langenfeld, S. J., Shaffer, V. O., Thorsen, A. J., Weiser, M. R., Chang, G. J., Lightner, A. L., et al. (2022) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002323 · Cited by 401
Vogel, J. D., Eskicioglu, C., Weiser, M. R., Feingold, D. L., & Steele, S. R. (2017) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000926 · Cited by 342
Metadata
- Authors
- Franko, J., Ibrahim, Z., Gusani, N. J., Holtzman, M. P., Bartlett, D. L., & Zeh, H. J.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2010-08-04
- Volume
- 116
- Issue
- 16
- Pages
- 3756-3762
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2053510750
- Cited by
- 313
- References
- 20
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.